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Riskfactors,suchasparentalsmoking,arecommonlyassociatedwithincreasedasthmasymptomsandhospitalizationsofchildren.
Deseret Mutual Beneﬁts Administrators (DMBA) is the health insurer for employees of The Church of Jesus Christ of Latter-
day Saints and their families. Due to religious proscription, employees abstain from alcohol and tobacco use, creating a cohort
of children not exposed to parental smoking. Calculation of hospitalization rates for DMBA, Utah, and the US were made in
children to compare rates between a nonsmoking population and general populations. Compared to DMBA, rate ratios for
asthma hospitalization and emergency department asthma visits were higher for the US and Utah. The incidence of hospital
outpatient department and physician oﬃce visits was signiﬁcantly greater for the US population compared to the DMBA. This
study demonstrates a decreased need for health services used by children not exposed to second-hand smoke.
1.Introduction
Asthma is a chronic respiratory condition that aﬀects over 7
million United States (US) children [1]. Acute episodes are
characterized by airway constriction and excess production
of mucus and may require medication to restore normal
breathing. Several diﬀerent triggers have been found to set
oﬀepisodes,includingcoldordryair,dust,pollen,pollution,
physical activity, stress, and cigarette smoke.
Parental cigarette smoking inﬂuences children’s asthma-
related symptoms. Children are more vulnerable to tobacco
smoke than adults because their respiratory and immune
systems are not completely developed [2]. As early as
1992, the Environmental Protection Agency reported that
environmental tobacco smoke (ETS) is causally associated
with 1 million episodes and increased severity of symptoms
among asthmatic children [3]. In addition, ETS is a risk
factorfornewasthmacasesinchildren[4].IntheUSin1997,
ﬁgures for childhood illness and death attributed parental
smoking with an estimated excess of 1.8 million outpatient
visits for asthma and an excess of 14 asthma deaths [5].
A worldwide study conducted in 2004 found that 603,000
deaths were attributableto ETS exposure, 28% of which were
in children [6].
Deseret Mutual Beneﬁts Administrators (DMBA) is the
health insurer for employees of The Church of Jesus Christ
of Latter-Day Saints (LDS) and their families, with electronic
data for 62,000 individuals. Due to religious proscription,
those who work for the LDS church are required to abstain
from alcohol and tobacco use, creating a cohort of children
not exposed to parental smoking. Utah’s rate for lung cancer
traditionally is about half that of the US [7]. Non-LDS in
Utah have 1.6x (male) and 2.2x (female) higher rates of
smoking-related cancers, compared to their LDS counter-
parts [8]. Not everyone who is listed on the membership
records of the LDS church adheres to the teachings regarding
abstinence from smoking; however, those employed by the
church, and therefore under DMBA coverage, are required
to state they follow the nonsmoking requirement. Thus, we
would expect to see a gradient of smoking-related disease,
with the lowest rates found in the DMBA population and the
highest rates in the US. The rates for Utah, with its large
LDS population, should be intermediate between the DMBA
and US rates. This study compares the childhood asthma
hospitalization rates of a nonsmoking population (DMBA
enrollees) to Utah and US hospitalization rates to determine
the impact of smoking on these rates. It also examines the
eﬀect of smoking on utilization of asthma-related outpatient2 ISRN Pediatrics
medical services, including emergency department (ED)
visits.
2. Methods
2.1. Study Population. The DMBA insurance claims database
was used to estimate childhood hospitalization rates from
1997–2002 among a nonsmoking population. The DMBA
was established in 1970 to provide insurance to the employ-
ees of the LDS Church and their families. Electronic data
recording began in 1995 and was completed by the end of
1996. Study data collection covers the years 1997–2002. The
DMBA is a national insurance claims database that insures
approximately 62,000 members a year with nearly equal
numbers of males and females. Utah residents under the age
of eighteen comprise approximately 35% of the database,
and analysis was limited to this population. The DMBA
population has little employment turnover, estimated at less
than 5% per year, providing a stable population for analyses.
The majority of turnover occurs because of the addition
of newborns, the loss of young adults who marry, move
out of the parental home, or reach age 26, and individuals
who become eligible for Medicare. The University of Utah’s
Institutional Review Board approved this study as low risk.
2.2. National Hospital Discharge Survey. The National Hos-
pital Discharge Survey (NHDS) is an annual national prob-
ability survey that collects information on characteristics of
inpatients discharged from non-Federal short-stay hospitals
in the United States. The NHDS collects data from a sample
of approximately 270,000 inpatient records acquired from
about 500 hospitals. Reported data include number and rate
of discharge and average length of stay by age, sex, and
geographicregion.OnlyﬁrstlisteddiagnosesofInternational
Classiﬁcation of Disease, 9th Revision, Clinical Modiﬁcation
(ICD-9), are used to deﬁne disease [9]. Data for this study
covers the years 1997–2001.
2.3. National Ambulatory Medical Care Survey. The National
Ambulatory Medical Care Survey is an annual national sur-
vey that is designed to collect data on the use of ambulatory
care services in the United States. Results are based on a
national sample of visits to nonfederally employed oﬃce-
based physicians who are primarily engaged in direct patient
care. Specially trained interviewers visit the physicians prior
to participation to train them in data collection procedures.
Each physician is randomly assigned a 1-week reporting
period. Data include information about physician diagnoses,
medicationsorderedorprovided,patientdemographics,and
services provided [10]. Data for this study covers the years
1997–2002.
2.4. National Hospital Ambulatory Medical Care Survey.
The National Hospital Ambulatory Medical Care Survey
is a survey designed to collect data on the utilization of
ambulatory services in hospital emergency and outpatient
departments. Findings are based on a national sample of vis-
its to emergency and outpatient departments of noninstitu-
tional and short-stay hospitals, exclusive of federal hospitals,
military hospitals, Veterans Administration hospitals, psy-
chiatric institutions, and long-term care facilities. Specially
trained interviewers visit hospitals prior to participation
to explain survey completion procedures. Hospital staﬀ
complete annual surveys during a 4-week period. Collected
data include patient demographics, physician diagnoses,
services and procedures provided, and medication provided
[11]. Data for this study covers the years 1997–2002.
2.5. National Health Interview Survey. The National Health
Interview Survey (NHIS) is an annual survey conducted by
the Centers for Disease Control and Prevention’s National
Center for Health Statistics and provides national estimates
for a broad range of health measures for children less
than 18 years of age. Each year, a representative number
of households across the United States are selected using
a multistage cluster sample design. The annual NHIS
questionnaire is administered to the entire household. Child
health information, utilization of health care services, house-
hold composition, and sociodemographic characteristics
are ascertained by asking a knowledgeable family member,
aged 18 years or older, who resides in the household.
Two questions are asked to determine the prevalence and
frequency of asthma: “ever told had asthma,” and “had an
asthma attack in the last 12 months” [12]. Data for this study
covers the years 1997–2002.
2.6. Utah’s Indicator-Based Information System for Public
Health. The Utah Indicator-Based Information System for
Public Health contains data on all hospitalizations from the
49 Utah hospitals operating during the study period. Billing,
medical, and demographic information describing a patient,
the services received, and inpatient charges are collected
quarterly [13]. Hospital discharge diagnosis, based on ICD-
9 codes was used to identify inpatient hospitalizations for
asthma. Data for this study covers the years 1999–2002.
2.7. Asthma Case Deﬁnition. Asthma cases were deﬁned
using the primary ICD-9 diagnosis codes 493.00–493.99.
DMBA asthma services prevalence was determined by
dividing all individuals with an asthma claim within a
calendar year by the population of those <18 in that year.
Multiple claims could be generated at a single visit in
o r d e rt op r o v i d ef o rd i ﬀering points of service. In our
data, these claims were associated and counted as a single
visit. However, if treatment for asthma was sought more
than once during a year, each visit was counted separately.
Stratiﬁcations were made by sex, age (<5, 5–11, 12–17
years), calendar year, and season (Mar–May, Jun–Aug, Sept–
Nov, Dec–Feb). Ambulatory visits were broken down into
physicianoﬃcevisits,outpatientvisits,andEDvisitsinorder
to establish utilization rates. Outpatient and physician oﬃce
visit information was not available for Utah.
2.8. Statistical Analysis. Utilization rates in DMBA were
compared to the state and national data sources by calculat-
ing rate ratios (RR) with 95% conﬁdence intervals (CI) [14].
One-wayanalysisofvariance(ANOVA)wasconductedusing
SAS, version 9.1, to determine diﬀerences in age-speciﬁcISRN Pediatrics 3
Table 1: Characteristics for the DMBA population from 1997–2002 for individuals less than 18 years of age that reside in Utah.
1997 1998 1999 2000 2001 2002 Combined
DMBA population 13,318 13,511 14,128 14,187 14,470 14,460 84,074
Asthma cases
0 – 4 y e a r s 4 65 66 36 08 19 5 4 0 1
5–11 years 104 111 124 114 124 135 612
12–17 years 131 142 148 117 163 155 856
Total 281 309 335 291 368 385 1,969
Mean age
All children 10.30 10.21 10.00 9.80 9.72 9.62 9.94




2.16 2.10 1.96 1.93 2.14 1.90 2.03
aAny visit to a hospital, emergency department, outpatient hospital department, or a physician oﬃce.
Table 2: Age- and sex-speciﬁc asthma hospital dischargea rates and rate ratios for DMBA, Utah, and United States, 1997–2001.
Discharge rate per 1000 Rate ratiob (95% conﬁdence interval)
Age (yr) DMBA Utah US Utah US
Male
0–4 2.08 4.36 7.06 2.10 (1.24–3.54) 3.39 (2.01–5.73)
5–11 0.70 1.34 2.74 1.91 (0.99–3.69) 3.91 (2.04–7.52)
12–17 0 0.98 1.04 —c —c
All ages 0.65 2.11 3.35 3.25 (2.16–4.89) 5.15 (3.43–7.75)
Female
0–4 1.08 2.73 4.16 2.53 (1.20–5.31) 3.85 (1.84–8.08)
5–11 0.65 0.95 1.82 1.46 (0.73–2.93) 2.80 (1.40–5.60)
12–17 0.07 1.34 1.14 19.14 (2.88–127.10) 16.29 (2.46–108.00)
All ages 0.47 1.6 2.22 3.40 (2.20–5.27) 4.72 (2.90–7.71)
Total
0–4 1.59 3.57 5.61 2.25 (1.46–3.45) 3.53 (2.30–5.41)
5–11 0.68 1.15 2.28 1.69 (1.05–2.72) 3.35 (2.09–5.38)
12–17 0.03 1.15 1.09 38.33 (5.60–290.33) 36.33 (4.80–275.00)
All ages 0.56 1.87 2.80 3.34 (2.44–4.47) 5.00 (3.65–6.84)
aICD-9 codes 493.00–493.99 as reported by the Utah Indicator-Based Information System for Public Health (Utah rates) and the National Hospital
Ambulatory Medical Care Survey (US rates)
bReferent category is DMBA
cNo cases were reported in DMBA, precluding comparison to DMBA.
seasonal asthma cases. The level of signiﬁcance was set at
alpha = 0.05 using a two-tailed test.
3. Results
Baseline characteristics for the DMBA population are shown
in Table 1. The average number of health care utilizations for
asthma in children was 2.03 per year (95% CI 1.74–2.34).
Age- and sex-speciﬁc hospital discharge rates for asthma
are presented in Table 2 for the DMBA and comparison
populations. A similar trend was seen in all populations,
with asthma discharge rates for males 30–50% higher than
for females. The DMBA had the lowest discharge rate for
a l la g e sa c r o s sb o t hs e x e s ,w i t hU t a hr a t e si n t e r m e d i a t e
between DMBA and US rates. Hospitalizations among US
childrenwere5timeshigher(95%CI3.65–6.84)thanamong
DMBA children. Hospitalizations among Utah children were
3.34 times higher (95% CI 2.44–4.47) than among DMBA
children. Average length of stay was similar between the
DMBA and comparison populations, at about three days
(data not shown).
A similar pattern was seen for visits to ED and outpatient
clinics (Table 3). Relative to children in DMBA, emergency
departmentvisitswere4.00(95%CI:3.50–4.56)timeshigher
for US children and 1.20 (95% CI: 1.05–1.37) times higher
for Utah children. Relative to children in DMBA, hospital
outpatient department visits were 5.56 (95% CI: 4.64–6.65)
times higher for US children. Relative to children in DMBA,
physician’s oﬃce visits were 1.65 (95% CI: 1.60–1.71) times
higher for US children. Data were not available to make Utah
to DMBA comparison for hospital outpatient or physician’s
oﬃce visits.
As seen in Figure 1, utilization of health services for
asthma was generally highest for those aged 0–4 years, and
there was no signiﬁcant variation in utilization by season
in this age group (P = 0.19). There was seasonal variation4 ISRN Pediatrics
Table 3: Average annual age-speciﬁc asthmaa utilization rates for DMBA, Utah, and United States by location of care, 1997–2002.
Utilization rate per 1000 Rate ratio (95% conﬁdence interval)
Location Age (yr) DMBA Utah US Utah US
Emergency
departmentb
0–4 4.68 4.56 15.70 0.97 (0.78–1.22) 3.35 (2.68–4.19)
5–11 2.46 2.61 9.76 1.07 (0.85–1.34) 3.97 (3.16–4.97)
12–17 1.71 2.19 6.82 1.28 (1.00–1.64) 4.00 (3.12–5.09)




0–4 1.23 —d 10.69 —d 8.69 (5.61–13.44)
5–11 1.35 —d 7.79 —d 5.77 (4.25–7.82)
12–17 1.53 —d 5.40 —d 3.53 (2.72–4.57)
All ages 1.40 —d 7.78 —d 5.56 (4.64–6.65)
Physician oﬃcec
0–4 33.73 —d 70.04 —d 2.08 (1.91–2.25)
5–11 34.12 —d 60.45 —d 1.77 (1.67–1.88)
12–17 35.94 —d 38.61 —d 1.07 (1.02–1.13)
All ages 34.85 —d 57.67 —d 1.65 (1.60–1.71)
aICD-9 codes 493.00–493.99
bNational Hospital Ambulatory Medical Care Survey
cNational Ambulatory Medical Care Survey




























and utilization for older age groups, with summer having
the lowest rates for both ages 5–11 (P = 0.005) and 12–17
(P = 0.05).
The prevalence of asthma was estimated for DMBA
as the proportion of children with any claim for asthma-
related services (ICD-9 493.00–493.99), and compared with
NHIS survey prevalence of asthma for the US (Table 4). The
prevalence for DMBA children was relatively constant across
the age groups 0–4 years, 5–11 years, and 12–17 years, while
there was a noticeable increase in prevalence for US children
as age increased. The relative prevalence of asthma was 3–6
times higher for US children compared to DMBA children.
Table 4: Age-speciﬁc asthma services prevalence per 1000 and rate
ratios for the DMBAa and United Statesb, 1997–2002.
Prevalence per 1000
Age (yr) DMBA US Rate ratio (95%
conﬁdence interval)
0–4 24.73 75.79 3.06 (2.77–3.37)
5–11 23.36 126.15 5.40 (5.02–5.80)
12–17 22.92 146.23 6.38 (5.97–6.82)
aDMBA prevalence was determined by dividing all individuals with an
asthma claim (ICD-9 codes 493.00–493.99) by the population of those less
than18 years of age in that year.
bNational Health Interview Survey.
4. Discussion
4.1. Study Summary. All measures of asthma service utiliza-
tion were lower in the DMBA pediatric population than in
comparison groups in the US and Utah. We hypothesized
that asthma services utilization would follow the same trend
seen for other smoking-associated diseases, with DMBA
having the lowest rate, Utah having an intermediate rate, and
the US having the highest rate, based on the prevalence of
smoking in these populations. This trend was documented
for asthma hospitalizations (3.3-fold and 5.0-fold higher in
Utah and the US, resp., compared to DMBA) and ED visits
(20% higher in Utah and 4-fold higher in the US). For
outpatient visits, data were only available for the DMBA and
US populations. Visits to hospital outpatient departments
were 5.6-fold higher for US relative to DMBA children,
and visits to physician’s oﬃces were 1.7-fold higher for US
relative to DMBA children. The prevalence ratio for asthma
services used, regardless of location of care, was higher for
US children than for DMBA children, ranging from 3.1 for
children age 0–4 years to 6.4 for children age 12–17 years.ISRN Pediatrics 5
One of this study’s strengths is that it included males
and females in a very stable population, ranging from 0–
17 years of age. Those covered under the DMBA insurance
have a low turnover rate, estimated at less than 5% per
year, providing a stable population for analyses. The DMBA
population was limited to the insured employees and their
families, who work for and are members of the Church of
Jesus Christ of Latter-Day Saints. Members of this religion
abstain from alcohol and tobacco use, creating a cohort of
children not exposed to parental smoking. This created a
unique opportunity to use population-based data to study
the impact of environmental tobacco smoke on childhood
asthma hospitalization and health care service utilization.
4.2. Potential for Biases. While there is no direct information
available on smoking for individuals who are covered by
the DMBA, it is a requirement to abstain from smoking to
retain employment. The low lung cancer rates in the DMBA
populationsupportthepremisethatitisprimarilycomposed
of nonsmokers. Additionally, studies have documented rates
of smoking-related cancers in LDS populations that are
about half that seen in the US and about two-thirds that
seen in Utah [8, 15]. The possibility exists that despite the
employed parent being required to abstain from tobacco use,
a spouse or child could potentially be a smoker and still
be covered by the DMBA. This would reduce the exposure
diﬀerence between the DMBA and comparison groups,
leading to an underestimate of the RR for children living in
nonsmoking households and would not change our overall
conclusion.
The DMBA is an insured population, so the use of ser-
vices could potentially be higher than the general population
where not all individuals have insurance coverage. The net
eﬀect of this bias would be that the RRs comparing other
populations to DMBA are an underestimate of the actual
amount of services used in the comparison populations.
Thus, this would not alter our conclusion.
Employed populations often have improved health when
comparedtothegeneralpopulation,speciﬁcallybecausethey
are healthy enough to be employed. We believe that the
health beneﬁts of employment are unlikely to explain the
lower childhood asthma rates, as the children themselves
are, for the most part, not employed. Higher socioeconomic
status within the DMBA population also does not explain
their lower childhood asthma rates, since the majority
(70.6%) of the employed individuals’ income is $60,000 or
less per year.
This study shares the limitations of all nonrandomized,
observational studies, including the possibility of selection
bias and unadjusted confounding. Using an insurance claims
database is more accurate than voluntary self-reporting
of illness, since physicians rely on ICD-9-CM codes for
reimbursement. Diagnostic discharge data were used in
this study in order to reﬂect actual diagnosis rather than
claims attempting to rule out asthma, which could have
overestimated the use of services. While discharge data are
subject to diagnostic inaccuracy, these errors are likely to
be distributed randomly through all databases and should
not bias our comparisons. Comparisons made between the
DMBA, the state of Utah, and the US were based on
standard deﬁnitions of disease, and there should be no bias
associated with the comparisons. Comparisons in this study
weremadebetween age-and sex-speciﬁc groupstominimize
confounding due to these factors.
4.3. Comparison with Previous Studies. Akinbami and
Schoendorf studied national asthma health care utilization
in physician oﬃces, hospital EDs, and hospital outpatient
departments. Their reported asthma rates for hospitaliza-
tion, ED and outpatient visits, and oﬃce visits were similar
to the US rates we have reported [16]. DMBA rates were
signiﬁcantly lower than those reported by Akinbami, as well
as Utah, and US rates (Table 3).
In a 2004 study conducted by Sturm et al., after
adjusting for sex, race, socioeconomic status, and a variety of
environmental factors, those who were exposed daily to ETS
were 1.72 times more likely to have active, diagnosed asthma
(deﬁned as self-reported asthma symptoms in children with
a previous diagnosis of asthma) and 1.86 times more likely to
have experienced wheezing in the last 12 months. The risk of
asthmadiagnosisandincreasedasthmasymptomsassociated
with ETS illustrates a dose response pattern, with a small but
signiﬁcantly increased risk among those exposed less than
once a month and a much larger risk among those exposed
daily [4].
Several studies have reported on the seasonal variation in
asthma.Flemingfoundthatratesforhospitaladmissionsand
asthma episodes were highest during September and lowest
during August for children in both age groups 0–4 and 5–
14 [17]. Weiss reported that hospitalizations peaked between
SeptemberandNovemberforthoseage5–34years[18].Khot
and Burn also found that admissions peaked in the fall [19].
Our study found that rates in the DMBA for children 5–11
and 12–17 peaked in the fall (September to November), but
that rates for the age group 0–4 were highest in the winter
months (November to February). The diﬀerence between
our study and that of Khot and Burn for the age group 0–
4 might be attributed to regional diﬀerences between Utah
and Great Britain. In Utah, children without fully developed
immune and respiratory systems are likely to be more at
risk due to the harsh winter climate. This could lead to a
greater frequency of upper respiratory infections and asthma
prevalence in the winter for the youngest age group.
Several studies have sought to address the eﬀects of
parental smoking and medical visits for childhood asthma.
Thyrian et al., Evans et al., and Jindal and Gupta studied
the impact of ETS on children and found that smoking in
the home was signiﬁcantly associated with an increase of
ED visits and hospitalizations [20–22]. Mackay et al. studied
the inﬂuence of smoke-free legislation on admissions for
childhood asthma. Before legislation was implemented, they
found admissions increasing at 5.2% per year; however, after
legislation implementation in March 2006, a decrease of
a d m i s s i o n so f1 8 . 2 %p e ry e a rw a sf o u n dr e l a t i v et op r e l e g -
islation rates [23]. Wilson et al. conducted a randomized
controlled trial highlighting a reduction in acute asthma
medical visits and overall healthcare utilization for children
whose parents were assigned to smoking-cessation classes6 ISRN Pediatrics
[24]. Similar to our study, these studies document that
reductions in ETS exposure reduce outpatient visits, ED
visits, and hospitalizations in children.
5. Conclusion
Utilization rates for hospitalization, ED, outpatient depart-
ment, and physician oﬃce visits were signiﬁcantly lower in
the nonsmoking group formed by the DMBA population
when compared to the US Utilization rates for hospital-
ization and ED visits for Utah children were intermediate
between DMBA and US rates. The comparison of the DMBA
tostateandnationalratesdemonstratesthemagnitudeofthe
diﬀerence between populations exposed to ETS versus those
who are not exposed.
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